Hosted on MSN
Zepbound boost gets a lift from Arrowhead’s drug. The question is whether patients will pay.
An experimental drug from the biotech Arrowhead Pharmaceuticals helped patients on Eli Lilly’s Zepbound lose even more weight in a clinical trial, but big questions remain about how much patients will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results